genome Archives - Blogs & Articles

Speaker Spotlight – ‘AJAY NAIR’ : 3rd Annual MarketsandMarkets Single Cell Analysis Conference

June 2, 2022 MarketsandMarkets Conferences

The 3rd Annual MarketsandMarkets Single Cell Analysis Conference kicks off at the Hyatt Regency Boston/Cambridge on the 23rd & 24th of June 2022. With 100+ attendees & stellar presentations from over 15+ industry experts and leaders, the countdown has well & truly begun. As we look forward to the hosting you in person, our keynote speakers gear up to present their enriching presentations comprising insightful findings, ideas & their vision into the future of cell analysis. Ajay Nair, working as an Associate Research Scientist at the universally acclaimed Columbia University…

Ning Wang talks about “Single cell sequencing: a powerful approach to profile tumor microenvironment” at Advance Genetic Sequencing Virtual Conference 2021

September 7, 2021September 7, 2021 MarketsandMarkets Conferences

Ning is a bioinformatics scientist at Arcus Biosciences, where he is responsible for drug discovery, target identification, and indication prioritization in multiple immune-oncology drug programs. Notably, Ning pioneered the 3D organoids based drug response prediction technology, which largely facilitated cancer model selection. During his PhD, he studied with Professor Alexander Hoffmann at UCLA, where he built up computational framework to identify synergy between key immune response signaling pathways in macrophage. Ning holds a PhD in Bioinformatics from UCLA. Marketsandmarkets took this opportunity to pick his brains on the newfound developments…

Grace Zhao, Co-founder, Avida Biomed discusses- “Dual methylation and mutation analysis from a single input of plasma cfDNA without sample splitting”

September 2, 2021 MarketsandMarkets Conferences

Grace Zhao is a co-founder of Avida Biomed, a biotech start-up specializing in genomic technology innovation for molecular diagnostics. At Avida, Grace co-invented Point-n-Seq, a new platform technology to advance liquid biopsy for early detection of cancer and other diseases. Utilizing the ultra-efficient, hybridization-based pre-amplification enrichment of target molecules from nanogram level cell free DNA (cfDNA), Point-n-Seq enables the first targeted mutation and methylation cfDNA dual analysis solution on market. Grace is currently the head of clinical research defining and executing company-wide clinical research strategy. Before Avida, Grace co-founded AccuraGen,…

An Overview of Spatial Transcriptomics: Techniques and Applications With Cátia Moutinho of GWCCG

August 18, 2021August 18, 2021 MarketsandMarkets Conferences

Dr. Cátia Moutinho is the Associate Director of Garvan-Weizmann Centre for Cellular Genomics, at the Garvan Institute Sydney-Australia. Also, she is the Group Leader of the Single Cell Technology Development Team. Her group focuses on single-cell genomics development. She is a biologist by training, with a PhD in Biomedicine and a master in Clinical Trials and Medical Affairs. She has an extensive experience in the wet-lab, with a strong background in single-cell technology, as well as cancer genetics and epigenetics. Cátia is also co-founder of the Single-Cell Ninjas Project, a…

Delve into the new era of genome sequencing- MarketsandMarkets Advanced Genetic Sequencing Virtual Conference

July 15, 2021 MarketsandMarkets Conferences

July 12th, 2021- Genome sequencing is providing physicians with more data about the causes of cancer and changing the way some forms of the disease are treated. Continued advancements in sequencing technologies have fuelled the development of new sequencing applications. MarketsandMarkets is proud to announce the first edition of Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23rd & 24th of September 2021. A 2-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology…

Julie Schwedock from Takeda Pharmaceuticals speaks about LBPs: What to consider when choosing CDMOs.

January 11, 2021 MarketsandMarkets Conferences

Julie Schwedock, PhD is Associate Director of the Microbial Development Team at Takeda Pharmaceuticals. She leads a cross-functional Pharmaceutical Sciences team for Live Bacterial Products (LBPs) focused on treating dysbiosis of the gut microbiome. She also heads a functional line group that works on process development for microbial expression systems as well as LPBs. Prior to that she was Associate Director of Analytical Development and QC at Vedanta Biosciences, also working with LBPs, where she developed analytics in an uncertain regulatory landscape for a product now in Ph2 clinical trials. …